PE20090565A1 - Derivados de n-heteroaril-carboxamidas triciclicas, su preparacion y su aplicacion en terapeutica - Google Patents
Derivados de n-heteroaril-carboxamidas triciclicas, su preparacion y su aplicacion en terapeuticaInfo
- Publication number
- PE20090565A1 PE20090565A1 PE2008001286A PE2008001286A PE20090565A1 PE 20090565 A1 PE20090565 A1 PE 20090565A1 PE 2008001286 A PE2008001286 A PE 2008001286A PE 2008001286 A PE2008001286 A PE 2008001286A PE 20090565 A1 PE20090565 A1 PE 20090565A1
- Authority
- PE
- Peru
- Prior art keywords
- pirrolo
- heteroaryl
- monociclic
- fluorobenzyl
- imidazo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
REFERIDA A COMPUESTOS DERIVADOS DE N-HETEROARIL-CARBOXAMIDAS TRICICLICAS DE FORMULA (I) DONDE A CON EL ENLACE Z2-Z3 DEL BICICLO ES CICLOALQUILO(C4-C7), HETEROARILO MONOCICLICO O HETEROCICLO MONOCICLICO DE 4 A 7 MIEMBROS, INCLUIDOS LOS ATOMOS Z2 Y Z3; Z2, Z3, Z4 Y Z9 SON CADA UNO N O C; Z1, Z5, Z6, Z7 Y Z8 SON CADA UNO N, C O C-R2, DONDE R2 ES H, HALOGENO, ALQUILO(C1-C6), FLUOROALCOXI(C1-C6), ENTRE OTROS; W ES O O S; P ES INDOLILO, PIRROLO[2,3-c]PIRIDINILO, PIRROLO[3,2-b]PIRIDINILO, ENTRE OTROS; R3 Y R3' SON CADA UNO H, HALOGENO, ALQUILO(C1-C6), CICLOALQUILO(C3-C7), ENTRE OTROS. SON COMPUESTOS PREFERIDOS: N-(2.3-DIHIDRO-1H-PIRROLO[1'.2':1.2]IMIDAZO[5.4-b]PIRIDIN-6-IL)-5-FLUORO-1-(3-FLUOROBENCIL)-1H-INDOL-2-CARBOXAMIDA, N-(3-ACETOXI-2.3-DIHIDRO-1H-PIRROLO[1'.2':1.2]IMIDAZO[5.4-b]PIRIDIN-6-IL)-5-FLUORO-1-(3-FLUOROBENCIL)-1H-INDOL-2-CARBOXAMIDA, N-(2.3-DIHIDRO-3-OXO-1H-PIRROLO[1'.2':1.2]IMIDAZO[5.4-b]PIRIDIN-6-IL)-5-FLUORO-1-(3-FLUOROBENCIL)-1H-INDOL-2-CARBOXAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON ANTAGONISTAS DE LOS RECEPTORES DE TIPO TRPV1 SIENDO UTILES EN EL TRATAMIENTO DEL DOLOR OSTEOARTRITICO, NEUROPATICO, DIABETES, HIPERREFLEXIA VESICAL, CISTITIS, COLICO NEFRITICO, ULCERA DE ESTOMAGO, ENFERMEDAD DE CROHN, ASMA
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0705677A FR2919610B1 (fr) | 2007-08-02 | 2007-08-02 | Derives de n-heteroaryl-carboxamides tricycliques,leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20090565A1 true PE20090565A1 (es) | 2009-06-01 |
Family
ID=39185736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2008001286A PE20090565A1 (es) | 2007-08-02 | 2008-07-31 | Derivados de n-heteroaril-carboxamidas triciclicas, su preparacion y su aplicacion en terapeutica |
Country Status (24)
Country | Link |
---|---|
US (2) | US8153796B2 (es) |
EP (1) | EP2185558B1 (es) |
JP (1) | JP5259713B2 (es) |
KR (1) | KR20100041804A (es) |
CN (1) | CN101772499B (es) |
AR (1) | AR067754A1 (es) |
AU (1) | AU2008313601B2 (es) |
BR (1) | BRPI0814756A2 (es) |
CA (1) | CA2694994C (es) |
CL (1) | CL2008002289A1 (es) |
CO (1) | CO6251362A2 (es) |
EA (1) | EA017808B1 (es) |
FR (1) | FR2919610B1 (es) |
MA (1) | MA31687B1 (es) |
MX (1) | MX2010001238A (es) |
MY (1) | MY150428A (es) |
NZ (1) | NZ582970A (es) |
PA (1) | PA8790901A1 (es) |
PE (1) | PE20090565A1 (es) |
SG (1) | SG183080A1 (es) |
TW (1) | TWI366566B (es) |
UY (1) | UY31264A1 (es) |
WO (1) | WO2009050348A1 (es) |
ZA (1) | ZA201000745B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA032315B1 (ru) * | 2015-03-18 | 2019-05-31 | Бристол-Маерс Сквибб Компани | Замещенные трициклические гетероциклические соединения |
EP3320241A4 (en) | 2015-07-09 | 2018-07-18 | Vistadeltek, LLC | Control plate in a valve |
US10137211B2 (en) | 2015-08-28 | 2018-11-27 | Chdi Foundation, Inc. | Probes for imaging Huntingtin protein |
WO2022111473A1 (en) * | 2020-11-26 | 2022-06-02 | Bioardis Llc | Compounds as mrgprx2 antagonists |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0156327B1 (ko) * | 1995-07-12 | 1998-11-16 | 김종인 | 벤즈 또는 피리도이미다졸 유도체 |
US6313242B1 (en) * | 1996-05-20 | 2001-11-06 | Fina Technology, Inc. | Stereorigid bis-fluorenyl metallocenes |
US5708187A (en) * | 1996-06-27 | 1998-01-13 | Eli Lilly And Company | 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists |
ATE450533T1 (de) * | 2003-02-14 | 2009-12-15 | Glaxo Group Ltd | Carboxamidderivate |
WO2004108133A2 (en) * | 2003-06-05 | 2004-12-16 | Vertex Pharmaceuticals Incorporated | Modulators of vr1 receptor |
GB0319151D0 (en) * | 2003-08-14 | 2003-09-17 | Glaxo Group Ltd | Novel compounds |
FR2888847B1 (fr) * | 2005-07-22 | 2007-08-31 | Sanofi Aventis Sa | Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique |
FR2888848B1 (fr) * | 2005-07-22 | 2007-09-28 | Sanofi Aventis Sa | Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique |
FR2897061B1 (fr) * | 2006-02-03 | 2010-09-03 | Sanofi Aventis | Derives de n-heteroaryl-carboxamides tricycliques contenant un motif benzimidazole, leur preparation et leur application en therapeutique. |
-
2007
- 2007-08-02 FR FR0705677A patent/FR2919610B1/fr active Active
-
2008
- 2008-07-29 PA PA20088790901A patent/PA8790901A1/es unknown
- 2008-07-30 TW TW097128801A patent/TWI366566B/zh not_active IP Right Cessation
- 2008-07-31 BR BRPI0814756A patent/BRPI0814756A2/pt not_active IP Right Cessation
- 2008-07-31 JP JP2010518710A patent/JP5259713B2/ja not_active Expired - Fee Related
- 2008-07-31 KR KR1020107002302A patent/KR20100041804A/ko not_active Application Discontinuation
- 2008-07-31 WO PCT/FR2008/001141 patent/WO2009050348A1/fr active Application Filing
- 2008-07-31 CN CN2008801014470A patent/CN101772499B/zh not_active Expired - Fee Related
- 2008-07-31 MY MYPI20100448 patent/MY150428A/en unknown
- 2008-07-31 SG SG2012055265A patent/SG183080A1/en unknown
- 2008-07-31 EP EP08839139.6A patent/EP2185558B1/fr active Active
- 2008-07-31 CA CA2694994A patent/CA2694994C/fr not_active Expired - Fee Related
- 2008-07-31 PE PE2008001286A patent/PE20090565A1/es not_active Application Discontinuation
- 2008-07-31 NZ NZ582970A patent/NZ582970A/en not_active IP Right Cessation
- 2008-07-31 AR ARP080103318A patent/AR067754A1/es not_active Application Discontinuation
- 2008-07-31 EA EA201070217A patent/EA017808B1/ru not_active IP Right Cessation
- 2008-07-31 AU AU2008313601A patent/AU2008313601B2/en not_active Ceased
- 2008-07-31 MX MX2010001238A patent/MX2010001238A/es active IP Right Grant
- 2008-08-01 UY UY31264A patent/UY31264A1/es not_active Application Discontinuation
- 2008-08-01 CL CL2008002289A patent/CL2008002289A1/es unknown
-
2010
- 2010-01-29 US US12/696,149 patent/US8153796B2/en not_active Expired - Fee Related
- 2010-02-01 ZA ZA2010/00745A patent/ZA201000745B/en unknown
- 2010-02-01 CO CO10010102A patent/CO6251362A2/es active IP Right Grant
- 2010-03-01 MA MA32663A patent/MA31687B1/fr unknown
-
2012
- 2012-03-06 US US13/412,855 patent/US8420817B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20091307A1 (es) | Derivados de indol 2-carboxamidas y de azaindol 2-carboxamidas sustituidos con un grupo silanilo, su preparacion y su aplicacion en terapeutica | |
PE20081689A1 (es) | Derivados de n-(heteroaril)-1-heteroaril-1h-indol-2-carboxamidas y su preparacion | |
PE20050951A1 (es) | Compuestos mimeticos de glucocorticoides, metodos de preparacion y composiciones farmaceuticas | |
PE20091403A1 (es) | Derivados de carboxamidas n-azabiciclicas y su preparacion | |
ES2865330T3 (es) | Azabenzimidazoles y su uso como moduladores del receptor AMPA | |
BR0315547A (pt) | Derivados de quinolina como antagonistas de crth2 | |
PE20091320A1 (es) | Derivados de carboxamidas azabiciclicas, su preparacion y su aplicacion en terapautica | |
PE20142216A1 (es) | Inhibidores de indazol de la ruta de senalizacion de wnt y usos terapeuticos de los mismos | |
TW201011020A (en) | Substituted naphthyridines and their use as medicaments | |
CA2637333A1 (fr) | Derives de n-heteroaryl-carboxamides tricycliques contenant un motif benzimidazole, leur preparation et leur application en therapeutique | |
HUP0203872A2 (hu) | Helyettesített 4-(fenil-N-alkil)-piperazin és piperidinszármazékok, alkalmazásuk dopamin neurotranszmissziós modulátorként és ezeket tartalmazó gyógyszerkészítmények | |
NO20090979L (no) | (3-amino-1,2,3,4-tetrahydro-9H-karbazol-9-yl)-eddiksyrederivater | |
PE20090370A1 (es) | Derivados de heterociclo fusionado como inhibidores de quinasa | |
HUP0203873A2 (hu) | Szubsztituált indolvázú Mannich-bázisok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
ATE487715T1 (de) | Triazolderivate als modulatoren von dopamin-d3- rezeptoren | |
EP2235014A2 (fr) | Dérivés bicycliques de carboxamides azabicycliques, leur préparation et leur application en thérapeutique. | |
PE20091398A1 (es) | Compuestos biciclicos conteniendo nitrogeno activos en condiciones de dolor cronicas | |
PE20090565A1 (es) | Derivados de n-heteroaril-carboxamidas triciclicas, su preparacion y su aplicacion en terapeutica | |
PE20091350A1 (es) | Derivados de sulfonamidas sustituidas | |
PE20020927A1 (es) | Uso de agonistas inversos de gaba a en combinacion con agonistas parciales del receptor de nicotina, estrogenos, moduladores selectivos de estrogenos o vitamina e, para el tratamiento de trastornos cognitivos | |
TW200624432A (en) | Imidazo [1,2-a] pyridine compounds, compositions, uses and methods related thereto | |
GB0507601D0 (en) | Compounds | |
PE20090960A1 (es) | Derivados de quinazolinadiona, su preparacion y sus aplicaciones terapeuticas | |
PE20091083A1 (es) | Moduladores tieno- y furo- pirimidina del receptor de histamina h4 | |
PE20091436A1 (es) | Derivados de sulfonamidas sustituidas como moduladores b1r |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |